Green Ronald D has reported a recent stock transaction involving Neogen Corp, a company in the life sciences sector. This filing is significant as it shows the ongoing activity of insiders, which can provide insights into the company's equity management.
Background
Green Ronald D is associated with Neogen Corp, which operates under the SIC classification for in vitro and in vivo diagnostic substances. The company is listed under the CIK number 0000711377. Neogen Corp is incorporated in Michigan and focuses on developing products for food and animal safety.
What the Filing Says
According to the recent filing dated October 30, 2026, Green Ronald D reported a transaction on October 29, 2026, where he acquired 1,776 shares of Neogen Corp. The shares were acquired at a price of $12.21 per share, and following the transaction, he owns a total of 29,044 shares. The filing notes, "Each RSU is the economic equivalent of one share of common stock. On October 29, 2026, these RSUs vested and were settled for an equal number of shares of common stock."
Impact
This transaction may affect perceptions of Neogen Corp's stock among investors and analysts, as insider activity is often scrutinized for potential signals about a company's future performance. The life sciences industry is competitive and constantly evolving, and such transactions can indicate confidence in the company's direction.
What's Next
The filing does not say what happens next.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






